BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36826995)

  • 101. Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma.
    Krug A; Mhaidly R; Tosolini M; Mondragon L; Tari G; Turtos AM; Paul-Bellon R; Asnafi V; Marchetti S; Di Mascio L; Travert M; Bost F; Bachy E; Argüello RJ; Fournié JJ; Gaulard P; Lemonnier F; Ricci JE; Verhoeyen E
    Cell Death Discov; 2024 Jun; 10(1):292. PubMed ID: 38897995
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Peripheral T-cell lymphoma with TFH phenotype and associated indolent T-lymphoblastic proliferation.
    Symes E; Venkataraman G
    Blood; 2023 Aug; 142(5):493. PubMed ID: 37535366
    [No Abstract]   [Full Text] [Related]  

  • 103. Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph
    Hirabayashi S; Kondo T; Nishiwaki S; Mizuta S; Doki N; Fukuda T; Uchida N; Ozawa Y; Kanda Y; Imanaka R; Takahashi S; Ishikawa J; Yano S; Nakamae H; Eto T; Kimura T; Tanaka J; Ichinohe T; Atsuta Y; Kako S
    Am J Hematol; 2023 Oct; 98(10):1606-1618. PubMed ID: 37493218
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.
    Matthews AH; Perl AE; Luger SM; Gill SI; Lai C; Porter DL; Skuli S; Bruno XJ; Carroll MP; Freyer CW; Carulli A; Babushok DV; Frey NV; Hexner EO; Martin ME; McCurdy SR; Stadtmauer EA; Loren AW; Paralkar VR; Maillard IP; Pratz KW
    Am J Hematol; 2023 Aug; 98(8):1254-1264. PubMed ID: 37334852
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils.
    Zhou A; Shi C; Fan Y; Zheng Y; Wang J; Liu Z; Xie H; Liu J; Jiao Q
    Front Immunol; 2023; 14():1171308. PubMed ID: 37325657
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma.
    Armand P; Zinzani PL; Lee HJ; Johnson NA; Brice P; Radford J; Ribrag V; Molin D; Vassilakopoulos TP; Tomita A; von Tresckow B; Shipp MA; Herrera AF; Lin J; Kim E; Chakraborty S; Marinello P; Moskowitz CH
    Blood; 2023 Sep; 142(10):878-886. PubMed ID: 37319435
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Engaging stimulatory immune checkpoint interactions in the tumour immune microenvironment of primary liver cancers - how to push the gas after having released the brake.
    Rakké YS; Buschow SI; IJzermans JNM; Sprengers D
    Front Immunol; 2024; 15():1357333. PubMed ID: 38440738
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Analysis and Regulatory Mechanisms of Platelet-Related Genes in Patients with Ischemic Stroke.
    Li Y; Shu Y; Yu K; Ni R; Chu L
    Cell Mol Neurobiol; 2024 Jan; 44(1):15. PubMed ID: 38175286
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Advances in the pathogenesis and therapeutic strategies of angioimmunoblastic T-cell lymphoma.
    Zhang Q; Yin L; Lai Q; Zhao Y; Peng H
    Clin Exp Med; 2023 Dec; 23(8):4219-4235. PubMed ID: 37759042
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice.
    Gao J; Ren S; Choonoo G; Chen G; Frleta D; Zhong J; Gupta N; Sharma P; Oyejide A; Atwal GS; Macdonald L; Murphy A; Kuhnert F
    Dis Model Mech; 2023 Oct; 16(10):. PubMed ID: 37718909
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies.
    Braun T; Schrader A
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173999
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
    Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
    Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Update on peripheral T-cell lymphomas with T-helper phenotype:  Are there too many subtypes?
    Piris MA; Rodriguez-Pinilla SM; Santonja C; Betancor I; Alonso-Alonso R; Gru AA; Rodriguez M
    Semin Diagn Pathol; 2020 Jan; 37(1):24-31. PubMed ID: 31870687
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma.
    Chavez JC; Foss FM; William BM; Brammer JE; Smith SM; Prica A; Zain JM; Tuscano JM; Shah H; Mehta-Shah N; Geethakumari PR; Wang BX; Zantinge S; Wang L; Zhang L; Boutrin A; Zhao W; Cheng L; Standifer N; Hewitt L; Enowtambong E; Shao W; Sharma S; Carlesso G; Moscow JA; Siu LL
    Clin Cancer Res; 2023 May; 29(10):1869-1878. PubMed ID: 36826995
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Markers of Follicular Helper T Cells Are Occasionally Expressed in T-Cell or Histiocyte-Rich Large B-Cell Lymphoma, Classic Hodgkin Lymphoma, and Atypical Paracortical HyperplasiaA Diagnostic Pitfall For T-Cell Lymphomas of T Follicular Helper Origin.
    Abukhiran I; Syrbu SI; Holman CJ
    Am J Clin Pathol; 2021 Aug; 156(3):409-426. PubMed ID: 33624021
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression.
    Paik JH; Koh J; Han B; Kim S; Lee KR; Lee S; Lee JO; Kim TM; Kim WY; Jeon YK
    Hum Pathol; 2023 Jan; 131():47-60. PubMed ID: 36495942
    [TBL] [Abstract][Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.